Design
Review
Authors
Loading...
Supports INa,late as a therapeutic target in HF; leaves open clinical efficacy pending randomized trials.
This review highlights the pathophysiological role of the late sodium current in heart failure and the potential therapeutic value of its pharmacological modulation.
Horváth et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: